Dr. Wei Du 杜伟
Chief Physician
Department of Head, Neck and Thyroid Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of thyroid tumors, hypopharyngeal cancer, laryngeal cancer, oral and salivary gland tumors, and benign and malignant head and neck tumors.
Dr. Du holds a medical doctorate and serves as Deputy Director of the Head and Neck Thyroid Department at Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University). Dr. Du was a senior visiting scholar at the University Medical Center Hamburg-Eppendorf, affiliated with the University of Hamburg, Germany.
Professional roles
- Standing Committee Member, Thyroid Tumor Professional Committee, China Health Promotion Association
- Standing Committee Member, Otolaryngology Professional Committee, Henan Medical Association
- Vice Chair, Thyroid Youth Committee, Henan Medical Association
- Standing Committee Member, Cancer Screening and Early Diagnosis and Treatment Professional Committee, Henan Anti-Cancer Association
Name order: in Chinese the family name comes first (Du Wei). Papers usually list the name as Wei Du or Du W.
Selected publications
58 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2026 (senior author): Identification and validation of a prognostic signature comprising inflammation and pyroptosis-related genes in oral squamous cell carcinoma. PubMed 42483177
- BMC Cancer, 2026 (senior author): Betel nut chewing influences pathologic response in oral squamous cell carcinoma treated by neoadjuvant immunochemotherapy. PubMed 42337483
- Ann Surg Oncol, 2026 (senior author): Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage. PubMed 41299003
- BMC Oral Health, 2026 (senior author): Sentinel lymph node biopsy in cT1-2N0 lip squamous cell carcinoma: site-specific diagnostic accuracy, anatomic mapping, and survival impact. PubMed 41668105
- Front Immunol, 2025 (senior author): Anti-EGFR enhanced neoadjuvant immunotherapy versus neoadjuvant immunochemotherapy for locally advanced oral squamous cell carcinoma. PubMed 41357202
- BMC Oral Health, 2025 (senior author): Palate invasion in cT3/4 maxillary sinus squamous cell carcinoma: a study of at least 5-year follow-up. PubMed 41254629
- Front Oncol, 2025 (senior author): De-escalating adjuvant therapy after pathologic complete response in oral squamous cell carcinoma: Chemoradiotherapy benefits only high-risk subgroups. PubMed 41018074
- Front Immunol, 2025 (senior author): Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma. PubMed 40406105
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion